Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19 Read more
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2 Read more
Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy Read more
Roche And Prothena Will Advance Prasinezumab Into Late-Stage Clinical Development Study In Parkinson’s Disease Read more
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2 Read more
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy Read more
FDA approves Nucala as the first and only biologic treatment for Hypereosinophilic Syndrome (HES) Read more